Skip to main content
icon for Кого Трамп объявит следующим комиссаром FDA?

Кого Трамп объявит следующим комиссаром FDA?

icon for Кого Трамп объявит следующим комиссаром FDA?

Кого Трамп объявит следующим комиссаром FDA?

Стивен Хан <1%

Сара Бреннер <1%

Кайл Диамантис <1%

Нет объявления до 31 декабря <1%

Polymarket

$34,838 Объем

Стивен Хан <1%

Сара Бреннер <1%

Кайл Диамантис <1%

Нет объявления до 31 декабря <1%

Polymarket

$34,838 Объем

Кайл Диамантис

$8,320 Объем

<1%

Стивен Хан

$4,144 Объем

1%

Бретт Жируар

$5,265 Объем

<1%

Грейс Грэм

$6,683 Объем

<1%

Сара Бреннер

$7,418 Объем

1%

Нет объявления до 31 декабря

$3,007 Объем

<1%

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.The wide-open field for Trump's next FDA commissioner stems from Marty Makary's May 2026 resignation, which left Kyle Diamantas as acting head while the White House conducted a deliberate search amid competing priorities like food policy reforms and drug approvals. Low probabilities across listed names reflect fragmented early speculation—former commissioner Stephen Hahn and acting official Diamantas bring institutional continuity, Sara Brenner and Grace Graham offer policy and HHS ties, and Brett Giroir adds prior Trump-era experience—yet no candidate has secured decisive White House backing or Senate momentum. Recent finalist reports and confirmation timelines through an election year have kept trader consensus dispersed, with consolidation likely hinging on an official announcement, alignment with administration health goals, or shifts in congressional dynamics.

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner.

An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs.

Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner.

Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify.

A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate.

If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”.

The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
Объем
$34,838
Дата окончания
31 дек. 2026 г.
Открытие рынка
May 12, 2026, 7:59 PM ET
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.The wide-open field for Trump's next FDA commissioner stems from Marty Makary's May 2026 resignation, which left Kyle Diamantas as acting head while the White House conducted a deliberate search amid competing priorities like food policy reforms and drug approvals. Low probabilities across listed names reflect fragmented early speculation—former commissioner Stephen Hahn and acting official Diamantas bring institutional continuity, Sara Brenner and Grace Graham offer policy and HHS ties, and Brett Giroir adds prior Trump-era experience—yet no candidate has secured decisive White House backing or Senate momentum. Recent finalist reports and confirmation timelines through an election year have kept trader consensus dispersed, with consolidation likely hinging on an official announcement, alignment with administration health goals, or shifts in congressional dynamics.

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner.

An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs.

Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner.

Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify.

A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate.

If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”.

The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
Объем
$34,838
Дата окончания
31 дек. 2026 г.
Открытие рынка
May 12, 2026, 7:59 PM ET
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.

Не доверяй внешним ссылкам.

Часто задаваемые вопросы

«Кого Трамп объявит следующим комиссаром FDA?» — это рынок прогнозов на Polymarket с 6 возможными исходами, где трейдеры покупают и продают акции на основе своих прогнозов. Текущий лидирующий исход — «Стивен Хан» с 1%, за ним следует «Сара Бреннер» с 1%. Цены отражают вероятности сообщества в реальном времени. Например, акция по цене 1¢ означает, что рынок коллективно оценивает вероятность этого исхода в 1%. Эти коэффициенты постоянно меняются. Акции правильного исхода можно обменять на $1 каждую при разрешении рынка.

На сегодняшний день «Кого Трамп объявит следующим комиссаром FDA?» сгенерировал общий объём торгов $34.8K с момента запуска рынка May 12, 2026. Такой уровень активности отражает высокую вовлечённость сообщества Polymarket и гарантирует, что текущие коэффициенты формируются широким кругом участников рынка. Ты можешь отслеживать движение цен в реальном времени и торговать любым исходом прямо на этой странице.

Чтобы торговать на «Кого Трамп объявит следующим комиссаром FDA?», просмотри 6 доступных исходов на этой странице. Каждый исход показывает текущую цену, представляющую подразумеваемую вероятность рынка. Чтобы занять позицию, выбери исход, который считаешь наиболее вероятным, выбери «Да» для торговли в его пользу или «Нет» для торговли против, введи сумму и нажми «Торговать». Если твой выбранный исход окажется верным, твои акции «Да» принесут $1 каждая. Если нет — $0. Ты также можешь продать акции до разрешения.

Это очень открытый рынок. Текущий лидер для «Кого Трамп объявит следующим комиссаром FDA?» — «Стивен Хан» всего с 1%, а «Сара Бреннер» близко позади с 1%. Поскольку ни один исход не доминирует, трейдеры видят это как крайне неопределённую ситуацию, что может создавать уникальные торговые возможности. Эти коэффициенты обновляются в реальном времени, так что добавь эту страницу в закладки.

Правила разрешения «Кого Трамп объявит следующим комиссаром FDA?» точно определяют, что должно произойти, чтобы каждый исход был объявлен победителем, включая официальные источники данных, используемые для определения результата. Ты можешь просмотреть полные критерии разрешения в разделе «Правила» на этой странице над комментариями. Мы рекомендуем внимательно прочитать правила перед торговлей, так как они определяют точные условия, особые случаи и источники.